All Comments by Paul Coleman

  1. Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus.
  2. Aβ Star is Born? Memory Loss in APP Mice Blamed on Oligomer
  3. Brain imaging evidence of preclinical Alzheimer's disease in normal aging.
  4. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
  5. Role of genes and environments for explaining Alzheimer disease.
  6. Clustering expressed genes on the basis of their association with a quantitative phenotype.
  7. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.
  8. RNA splicing capability of live neuronal dendrites.
  9. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.
  10. Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.
  11. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
  12. Individual adult human neurons display aneuploidy: detection by fluorescence in situ hybridization and single neuron PCR.
  13. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.
  14. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.
  15. Looking outside the Brain for Early Signs of AD